Cholesterol down-regulates BK channels stably expressed in HEK 293 cells

PLoS One. 2013 Nov 18;8(11):e79952. doi: 10.1371/journal.pone.0079952. eCollection 2013.

Abstract

Cholesterol is one of the major lipid components of the plasma membrane in mammalian cells and is involved in the regulation of a number of ion channels. The present study investigates how large conductance Ca(2+)-activated K(+) (BK) channels are regulated by membrane cholesterol in BK-HEK 293 cells expressing both the α-subunit hKCa1.1 and the auxiliary β1-subunit or in hKCa1.1-HEK 293 cells expressing only the α-subunit hKCa1.1 using approaches of electrophysiology, molecular biology, and immunocytochemistry. Membrane cholesterol was depleted in these cells with methyl-β-cyclodextrin (MβCD), and enriched with cholesterol-saturated MβCD (MβCD-cholesterol) or low-density lipoprotein (LDL). We found that BK current density was decreased by cholesterol enrichment in BK-HEK 293 cells, with a reduced expression of KCa1.1 protein, but not the β1-subunit protein. This effect was fully countered by the proteasome inhibitor lactacystin or the lysosome function inhibitor bafilomycin A1. Interestingly, in hKCa1.1-HEK 293 cells, the current density was not affected by cholesterol enrichment, but directly decreased by MβCD, suggesting that the down-regulation of BK channels by cholesterol depends on the auxiliary β1-subunit. The reduced KCa1.1 channel protein expression was also observed in cultured human coronary artery smooth muscle cells with cholesterol enrichment using MβCD-cholesterol or LDL. These results demonstrate the novel information that cholesterol down-regulates BK channels by reducing KCa1.1 protein expression via increasing the channel protein degradation, and the effect is dependent on the auxiliary β1-subunit.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cell Membrane / drug effects
  • Cell Membrane / genetics
  • Cell Membrane / metabolism
  • Cholesterol / metabolism*
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism
  • Down-Regulation / drug effects
  • Down-Regulation / genetics*
  • HEK293 Cells
  • Humans
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits / genetics*
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits / metabolism*
  • Lipoproteins, LDL / genetics
  • Lipoproteins, LDL / metabolism
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Proteasome Endopeptidase Complex / genetics
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Subunits / genetics
  • Protein Subunits / metabolism
  • Proteolysis / drug effects
  • beta-Cyclodextrins / pharmacology

Substances

  • KCNMA1 protein, human
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
  • Lipoproteins, LDL
  • Protein Subunits
  • beta-Cyclodextrins
  • methyl-beta-cyclodextrin
  • Cholesterol
  • Proteasome Endopeptidase Complex

Grants and funding

The research was supported by a grant from Sun Chieh Yeh Heart Foundation of Hong Kong, and a grant (No. 81170137) from the National Nature Science Foundation of China. Wei Wu was supported by a Postgraduate Scholarship from the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.